|Target:||Pallas health reseach and consultancy|
|Seller||Pallas health research and consultancy shareholders
|Advisory sell side:||IRIS Corporate Finance | M&A Advisory
Legal Tree | Legal Advisory Corporate M&A
|Advisory Buy side:||Crossminds | M&A Advisory
Four & Five | Legal Advisory Corporate M&A
P95, a Belgian pharmaceutical company, has acquired Pallas health research and consultancy, a Dutch research and consultancy firm. P95 conducts epidemiological studies to help clients plan the development of new vaccines and monitor the effects of vaccines on the market. With this acquisition, P95 is able to conduct more studies itself and can handle larger orders from its clients.